Gottlieb, A. B., Armstrong, A. W., Merola, J. F., Napoli, A. ., Nowak, M., Banerjee, S., Lehman, T., & Mease, P. J. (2024). Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients with Active Psoriatic Arthritis: Results from a Phase 2 Trial. SKIN The Journal of Cutaneous Medicine, 8(2), s383. https://doi.org/10.25251/skin.8.supp.383